Cargando…
Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex
Mycobacterium avium complex (MAC) is a serious disease mainly caused by M. avium and M. intracellulare. Although the incidence of MAC infection is increasing worldwide, only a few agents are clinically used, and their therapeutic effects are limited. Therefore, new anti-MAC agents are needed. Approx...
Autores principales: | Hosoda, Kanji, Koyama, Nobuhiro, Kanamoto, Akihiko, Tomoda, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514863/ https://www.ncbi.nlm.nih.gov/pubmed/30995807 http://dx.doi.org/10.3390/molecules24081495 |
Ejemplares similares
-
Evaluation of Anti-Mycobacterial Compounds in a Silkworm Infection Model with Mycobacteroides abscessus
por: Hosoda, Kanji, et al.
Publicado: (2020) -
Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020) -
Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis
por: Yu, Xia, et al.
Publicado: (2022) -
In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus
por: Zhu, Rui, et al.
Publicado: (2022) -
Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus
por: Haste, Nina M., et al.
Publicado: (2010)